We are live on ! Find out more
DY

Dowling & Yahnke Portfolio holdings

AUM $2.15B Turnover 6.98%
1-Year Est. Return 10.82%
This Fund
S&P 500
This Quarter Est. Return
+9.19%
1 Year Est. Return
-10.82%
3 Year Est. Return
+34.82%
5 Year Est. Return
+71.23%
10 Year Est. Return
–
AUM
$1.3B
AUM Growth
+$93.3M
Cap. Flow
-$7.51M
Cap. Flow %
-0.58%
Top 10 Hldgs %
25.17%
Holding
390
New
85
Increased
121
Reduced
146
Closed
8
Avg Time Held
3.4 years
Top 10 Avg Time Held
2.6 years
Top 20 Avg Time Held
2.9 years

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$2.53M
2
DOCU icon
DocuSign
DOCU
+$1.16M
3
AAPL icon
Apple
AAPL
+$971K
4
MZTI icon
The Marzetti Company
MZTI
+$858K
5
MSFT icon
Microsoft
MSFT
+$723K

Sector Composition

Rank Sector Weight
1 Miscellaneous 24.98%
2 Technology 14.73%
3 Healthcare 13.63%
4 Financials 11.39%
5 Consumer Staples 9.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
APD icon
276
Air Products & Chemicals
APD
$66.4B
$260K 0.02%
1,108
-450
-29% -$102K
2019 Q2
2 quarters
GRFS icon
277
Grifois
GRFS
$5.25B
$255K 0.02%
10,955
-47
-0.4% -$1.02K
2013 Q2
26 quarters
WEC icon
278
WEC Energy
WEC
$35.1B
$253K 0.02%
2,738
+85
+3% +$7.75K
2019 Q2
2 quarters
EW icon
279
Edwards Lifesciences
EW
$50B
$248K 0.02%
3,186
-24
-0.7% -$1.87K
2019 Q3
1 quarter
GDX icon
280
VanEck Gold Miners ETF
GDX
$26.2B
$246K 0.02%
8,400
– –
2019 Q3
1 quarter
DD icon
281
DuPont de Nemours
DD
$17.7B
$245K 0.02%
3,044
-220
-7% -$18.3K
2017 Q3
9 quarters
IAU icon
282
iShares Gold Trust
IAU
$61.8B
$244K 0.02%
8,412
– –
2019 Q3
1 quarter
IYH icon
283
iShares US Healthcare ETF
IYH
$4.18B
$243K 0.02%
5,625
-75
-1% -$3.03K
2018 Q4
4 quarters
ECL icon
284
Ecolab
ECL
$81.2B
$242K 0.02%
1,254
+62
+5% +$11.8K
2019 Q2
2 quarters
ICE icon
285
Intercontinental Exchange
ICE
$89.2B
$232K 0.02%
2,504
+181
+8% +$16.8K
2019 Q2
2 quarters
NVS icon
286
Novartis
NVS
$287B
$232K 0.02%
2,452
-41
-2% -$3.68K
2018 Q4
4 quarters
XLP icon
287
State Street Consumer Staples Select Sector SPDR ETF
XLP
$14.6B
$226K 0.02%
3,587
-165
-4% -$10.2K
2019 Q1
3 quarters
DOW icon
288
Dow Inc
DOW
$21.5B
$220K 0.02%
4,017
-285
-7% -$14.7K
2019 Q2
2 quarters
IYF icon
289
iShares US Financials ETF
IYF
$3.86B
$218K 0.02%
3,170
– –
2019 Q3
1 quarter
OMC icon
290
Omnicom Group
OMC
$22.1B
$215K 0.02%
2,657
+63
+2% +$4.94K
2019 Q2
2 quarters
DEO icon
291
Diageo
DEO
$53B
$213K 0.02%
1,262
+40
+3% +$6.5K
2019 Q2
2 quarters
ED icon
292
Consolidated Edison
ED
$41.3B
$212K 0.02%
2,339
– –
2019 Q2
2 quarters
LUMN icon
293
Lumen Technologies, Inc. Common Stock
LUMN
$4.83B
$211K 0.02%
15,954
+2,775
+21% +$37.2K
2019 Q3
1 quarter
VYM icon
294
Vanguard High Dividend Yield ETF
VYM
$81.7B
$211K 0.02%
2,257
– –
2019 Q3
1 quarter
HSY icon
295
Hershey
HSY
$34.4B
$204K 0.02%
1,390
-15
-1% -$2.22K
2019 Q3
1 quarter
AZO icon
296
AutoZone
AZO
$50.5B
$203K 0.02%
+170
New +$196K
2019 Q4
0 quarters
VOE icon
297
Vanguard Morningstar Mid-Cap Value ETF
VOE
$24B
$203K 0.02%
+1,699
New +$196K
2019 Q4
0 quarters
IWD icon
298
iShares Russell 1000 Value ETF
IWD
$83.7B
$202K 0.02%
1,480
-420
-22% -$55.4K
2015 Q4
16 quarters
IYJ icon
299
iShares US Industrials ETF
IYJ
$2.03B
$174K 0.01%
+2,078
New +$170K
2019 Q4
0 quarters
GWX icon
300
State Street SPDR S&P International Small Cap ETF
GWX
$908M
$167K 0.01%
+5,228
New +$161K
2019 Q4
0 quarters

Similar funds

Dowling & Yahnke's Q4 2019 Portfolio in Review

As of Q4 2019, Dowling & Yahnke held 390 positions worth $1.3B, up 7.7% from $1.21B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Dowling & Yahnke's Q4 2019 filing shows 85 new, 121 increased, 146 reduced and 8 closed positions. Its largest new stake was iShares National Muni Bond ETF: 4,701 shares worth $535K. The largest sale was Celgene Corp, an estimated $2.53M.

By sector, the portfolio is most concentrated in Miscellaneous at 25% of assets, down from 25% a quarter earlier, followed by Technology and Healthcare.

  • Dowling & Yahnke's largest Q4 2019 buy was iShares National Muni Bond ETF: 4,701 shares worth $535K.
  • Dowling & Yahnke added most to Bristol-Myers Squibb in Q4 2019, an estimated $1.6M increase.
  • Dowling & Yahnke's biggest Q4 2019 reduction was DocuSign, cutting an estimated $1.16M.
  • Dowling & Yahnke fully exited Celgene Corp in Q4 2019, selling an estimated $2.53M.
  • Dowling & Yahnke's ten largest holdings make up 25% of its $1.3B portfolio in Q4 2019.
  • Dowling & Yahnke opened 85 new positions and closed 8 in Q4 2019.
  • Dowling & Yahnke's portfolio value rose 7.7% quarter-over-quarter to $1.3B.

Based on Dowling & Yahnke's 13F filing for Q4 2019, filed 27 Jan 2020.